Literature DB >> 21355845

FAK and p53 protein interactions.

Vita M Golubovskaya1, William G Cance.   

Abstract

Focal Adhesion Kinase plays a major role in cell adhesion, motility, survival, proliferation, metastasis, angiogenesis and lymphangiogenesis. In 2004, we have cloned the promoter sequence of FAK and found that p53 inhibits its activity (BBA, v. 1678, 2004). In 2005, we were the first group to show that FAK and p53 proteins directly interact in the cells (JBC, v. 280, 2005). We have shown that FAK and p53 proteins interact in the cytoplasm and in the nucleus by immunoprecipitation, pull-down and confocal microscopy assays. We have shown that FAK inhibited activity of p53 with the transcriptional targets: p21, Bax and Mdm-2 through protein-protein interactions. We identified the 7 amino-acid site in p53 that is involved in interaction with FAK protein. The present review will discuss the interaction of FAK and p53 proteins and discuss the mechanism of FAK-p53 loop regulation: inhibition of FAK promoter activity by p53 protein and also inhibition of p53 transcriptional activity by FAK protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21355845      PMCID: PMC3184193          DOI: 10.2174/187152011796817619

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  27 in total

1.  Nuclear localization and apoptotic regulation of an amino-terminal domain focal adhesion kinase fragment in endothelial cells.

Authors:  M Lobo; I Zachary
Journal:  Biochem Biophys Res Commun       Date:  2000-10-05       Impact factor: 3.575

2.  Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB.

Authors:  V Benoit; E de Moraes; N A Dar; E Taranchon; V Bours; A Hautefeuille; P Tanière; A Chariot; J-Y Scoazec; C V de Moura Gallo; M-P Merville; P Hainaut
Journal:  Oncogene       Date:  2006-05-08       Impact factor: 9.867

3.  Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes.

Authors:  W G Cance; J E Harris; M V Iacocca; E Roche; X Yang; J Chang; S Simkins; L Xu
Journal:  Clin Cancer Res       Date:  2000-06       Impact factor: 12.531

4.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.

Authors:  L V Owens; L Xu; G A Dent; X Yang; G C Sturge; R J Craven; W G Cance
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

5.  Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53.

Authors:  Vita M Golubovskaya; Richard Finch; William G Cance
Journal:  J Biol Chem       Date:  2005-04-25       Impact factor: 5.157

6.  p53 regulates FAK expression in human tumor cells.

Authors:  Vita M Golubovskaya; Richard Finch; Frederick Kweh; Nicole A Massoll; Martha Campbell-Thompson; Margaret R Wallace; William G Cance
Journal:  Mol Carcinog       Date:  2008-05       Impact factor: 4.784

7.  Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.

Authors:  Vita Golubovskaya; Aparna Kaur; William Cance
Journal:  Biochim Biophys Acta       Date:  2004-05-25

8.  Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis.

Authors:  Lucia Beviglia; Vita Golubovskaya; LiHui Xu; XiHui Yang; Rolf J Craven; William G Cance
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

Review 9.  Focal adhesion kinase and p53 signal transduction pathways in cancer.

Authors:  Vita M Golubovskaya; William Cance
Journal:  Front Biosci (Landmark Ed)       Date:  2010-06-01

10.  Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis.

Authors:  D Ilić; E A Almeida; D D Schlaepfer; P Dazin; S Aizawa; C H Damsky
Journal:  J Cell Biol       Date:  1998-10-19       Impact factor: 10.539

View more
  24 in total

1.  DPP in the matrix mediates cell adhesion but is not restricted to stickiness: a tale of signaling.

Authors:  Asha Eapen; Amsaveni Ramachandran; Anne George
Journal:  Cell Adh Migr       Date:  2012-05-16       Impact factor: 3.405

2.  Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.

Authors:  Miodrag Dragoj; Jasna Bankovic; Evangelia Sereti; Sofija Jovanovic Stojanov; Konstantinos Dimas; Milica Pesic; Tijana Stankovic
Journal:  Invest New Drugs       Date:  2017-07-22       Impact factor: 3.850

Review 3.  FAK and Nanog cross talk with p53 in cancer stem cells.

Authors:  Vita M Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2013-05       Impact factor: 2.505

Review 4.  NANOG: a promising target for digestive malignant tumors.

Authors:  Ai-Xi Sun; Chang-Jiang Liu; Zi-Qin Sun; Zhi Wei
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

5.  Podocyte p53 Limits the Severity of Experimental Alport Syndrome.

Authors:  Ryosuke Fukuda; Mary Ann Suico; Yukari Kai; Kohei Omachi; Keishi Motomura; Tomoaki Koga; Yoshihiro Komohara; Kosuke Koyama; Tsubasa Yokota; Manabu Taura; Tsuyoshi Shuto; Hirofumi Kai
Journal:  J Am Soc Nephrol       Date:  2015-05-12       Impact factor: 10.121

Review 6.  The extracellular matrix modulates the hallmarks of cancer.

Authors:  Michael W Pickup; Janna K Mouw; Valerie M Weaver
Journal:  EMBO Rep       Date:  2014-11-08       Impact factor: 8.807

7.  The microarray gene profiling analysis of glioblastoma cancer cells reveals genes affected by FAK inhibitor Y15 and combination of Y15 and temozolomide.

Authors:  Grace Huang; Baotran Ho; Jeffrey Conroy; Song Liu; Hu Qiang; Vita Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

8.  Supervillin-mediated suppression of p53 protein enhances cell survival.

Authors:  Zhiyou Fang; Elizabeth J Luna
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

9.  Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations.

Authors:  Songjian Lu; Chunhui Cai; Gonghong Yan; Zhuan Zhou; Yong Wan; Vicky Chen; Lujia Chen; Gregory F Cooper; Lina M Obeid; Yusuf A Hannun; Adrian V Lee; Xinghua Lu
Journal:  Cancer Res       Date:  2016-10-10       Impact factor: 12.701

10.  Erythroid cells generated in the absence of specific β1-integrin heterodimers accumulate reactive oxygen species at homeostasis and are unable to mount effective antioxidant defenses.

Authors:  Tatyana Ulyanova; Yi Jiang; Steven M Padilla; Thalia Papayannopoulou
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.